SKP2 and renal cell carcinoma: Several statistical analyses showed that SKP2 promotes the progression and induces tumorigenesis of nasopharyngeal carcinoma (Yu et al., 2019) and accelerates the growth of renal cell carcinoma (Chen et al., 2021).